MGF IGF-1 EC (5mg) Peptide – Research Overview
MGF IGF-1 EC (5mg) is a laboratory research peptide classified as a splice variant of insulin-like growth factor-1 (IGF-1). Often referred to as Mechano Growth Factor (MGF) or IGF-1Ec, this peptide has drawn scientific interest for its role in mechanical stress signaling, localized tissue response, and cellular growth pathways.
At Core Peptide, we provide MGF IGF-1 EC (5mg) strictly for research and laboratory use, supplying high-purity peptide compounds to research facilities across the United States.
🔬 Browse additional compounds in our
Research Peptides Collection
What Is MGF IGF-1 EC?
MGF IGF-1 EC is an endogenously derived isoform of IGF-1, produced through alternative splicing of the IGF-1 gene. Unlike systemic IGF-1, IGF-1 EC contains a unique 49 base-pair insert at exon 5, which may introduce a structural frameshift and contribute to its distinct biological behavior.
Researchers have identified IGF-1 EC as a locally acting growth factor, meaning its activity appears concentrated at the site of mechanical stress or tissue strain rather than circulating systemically. This characteristic differentiates MGF IGF-1 EC (5mg) from other IGF-1 peptides commonly studied in endocrine research.
IGF-1 Splicing and Mechanical Stress Signaling
IGF-1 gene expression undergoes alternative splicing, resulting in three primary isoforms. The main distinction among these isoforms lies in their C-terminal amino acid sequences, which may influence receptor interactions and intracellular signaling.
MGF IGF-1 EC expression has been observed to increase significantly under mechanical load conditions, such as resistance-based muscle activity or tissue injury. Research suggests that:
-
Growth hormone may increase MGF expression by ~80% from baseline
-
Mechanical stress alone may elevate MGF mRNA levels by over 160%
-
Combined mechanical stress and hormonal signaling may amplify expression further
These observations have led scientists to investigate MGF IGF-1 EC (5mg) as a potential mediator of early cellular responses to mechanical strain.
Chemical Characteristics of MGF IGF-1 EC (5mg)
-
Molecular Formula: C₁₂₄H₂₀₄N₄₂O₄₁S
-
Molecular Weight: 2971.99 g/mol
-
Other Names: Mechano Growth Factor, IGF-1Ec, MGF-E
-
Form: Lyophilized powder
-
Quantity: 5mg vial
MGF IGF-1 EC (5mg) in Muscle Research
Muscle Cell Proliferation Models
One of the most studied applications of MGF IGF-1 EC involves muscle precursor (satellite) cells. In controlled cell culture experiments, synthetic MGF peptides—particularly the C-terminal E-domain—have been evaluated for their influence on muscle cell dynamics.
Observed outcomes in research settings include:
-
Increased myotube size
-
Elevated fusion index of muscle cells
-
Increased expression of muscle-specific contractile proteins
-
Reduced proportion of undifferentiated reserve cells
These findings suggest that MGF IGF-1 EC (5mg) may influence pathways associated with muscle cell differentiation and hypertrophic signaling under experimental conditions.:
PubMed – IGF-1 Isoforms and MGF E-Peptide
Muscle Recovery and Tissue Response Studies
MGF IGF-1 EC has also been examined in experimentally induced muscle injury models. In murine studies involving muscle contusion, exposure to MGF peptides was associated with:
-
Reduced inflammatory cytokine expression
-
Decreased oxidative stress markers
-
Lower expression of matrix metalloproteinases (MMPs)
-
Possible modulation of fibrotic signaling pathways
While satellite cell differentiation markers such as MyoD and myogenin appeared unchanged, researchers hypothesized that MGF IGF-1 EC may act by modulating the inflammatory microenvironment rather than directly driving satellite cell activation.
Anti-Apoptotic and Cardiac Research
MGF IGF-1 EC has been investigated in hypoxia-induced cardiac cell models to explore its potential role in programmed cell death (apoptosis). In these studies, MGF exposure appeared to:
-
Promote migration of mesenchymal stem cells toward hypoxic tissue
-
Increase expression of cell-survival genes such as Bcl-2
-
Reduce markers associated with apoptotic signaling
These observations have led researchers to suggest that MGF IGF-1 EC (5mg) may function as both a chemotactic signal and protective factor in cardiac tissue models under laboratory conditions.
Skeletal and Bone Injury Research
Animal studies evaluating bone defects have also included MGF IGF-1 EC in experimental protocols. Compared to IGF-1, MGF exposure appeared to:
-
Increase osteoblast-like cell proliferation
-
Improve radiographic bone healing outcomes
-
Enhance histological scores related to bone regeneration
Researchers have proposed that MGF IGF-1 EC may engage signaling pathways such as MAPK-Erk1/2, potentially influencing cell cycle regulation differently from systemic IGF-1.
Neuroprotective and Brain Research Models
MGF IGF-1 EC has been explored in brain ischemia and neurogenesis studies, particularly in animal models. Findings have included:
-
Increased endogenous MGF expression in ischemia-resistant neurons
-
Enhanced neuronal survival under hypoxic conditions
-
Elevated markers of neurogenesis, such as BrdU, in hippocampal regions
These results suggest that the C-terminal E-domain of IGF-1 EC may contribute to neuroprotective and proliferative signaling in controlled laboratory environments.
Why Choose Core Peptide?
Core Peptide is a trusted U.S. supplier of research-only peptides, offering:
High-purity, lab-verified compounds
Secure U.S.-based shipping
Transparent labeling and documentation
Strict research-use compliance
Explore more growth factor compounds in our
Peptide Research Library
References
-
Philippou A. et al., In Vivo Journal, 2009
-
IGF-1 Isoform Splicing Studies – PubMed
-
Muscle Injury and Growth Factor Research



Reviews
There are no reviews yet.